New 'Living Drug' trial offers hope for Tough-to-Treat blood cancer
NCT ID NCT05396885
Summary
This study is testing a personalized treatment called anitocabtagene-autoleucel for adults with multiple myeloma that has returned or stopped responding to standard therapies. Doctors take a patient's own immune cells, modify them in a lab to better target cancer, and infuse them back into the body. The main goal is to see how well this one-time treatment shrinks the cancer and how long the response lasts.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Colorado Blood Cancer Institute
Denver, Colorado, 80218, United States
-
Dana-Farber Cancer Institute
Boston, Massachusetts, 02115, United States
-
Froedtert Hospital & the Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
HonorHealth Cancer Transplant Institute
Scottsdale, Arizona, 85258, United States
-
Huntsman Cancer Institute, University of Utah
Salt Lake City, Utah, 84112, United States
-
John Theurer Cancer Center at Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Karmanos Cancer Institute
Detroit, Michigan, 48201, United States
-
Levine Cancer Institute
Charlotte, North Carolina, 28204, United States
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
-
Moffitt Cancer Center
Tampa, Florida, 33612, United States
-
Northside Hospital
Atlanta, Georgia, 30342, United States
-
Oregon Health & Science University (OHSU)
Portland, Oregon, 97239, United States
-
The University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
-
University of Arkansas for Medical Sciences
Little Rock, Arkansas, 72205, United States
-
University of Chicago Medical Center
Chicago, Illinois, 60637, United States
-
University of Maryland Greenebaum Comprehensive Cancer Center
Baltimore, Maryland, 21201, United States
-
University of Texas Southwestern Medical Center
Dallas, Texas, 75390, United States
-
University of Wisconsin Clinical Science Center
Madison, Wisconsin, 53792, United States
Conditions
Explore the condition pages connected to this study.